Company intelligence / Profile preview

SBRI

Seattle, Washington, United States
Ownership
Private
Employees
~325
Development stage
Other
01

Overview

Seattle Biomedical Research Institute (SBRI), later known as the Center for Infectious Disease Research (CIDR), was a prominent non-profit research organization dedicated to the discovery and development of treatments and vaccines for global infectious diseases. Founded in 1976, the institute became a world leader in the study of malaria, HIV/AIDS, and tuberculosis, utilizing advanced systems biology and structural genomics platforms. SBRI's research efforts led to the identification of numerous novel drug targets and the development of innovative vaccine candidates, including genetically attenuated parasite (GAP) vaccines for malaria. In 2018, the institute was integrated into the Seattle Children's Research Institute to form the Center for Global Infectious Disease Research, continuing its mission to eliminate devastating infectious diseases through scientific discovery.

Therapeutic areas
Infectious Diseases
Modalities
VaccineSmall moleculeMonoclonal antibody
Industry
Academic Hospital/University/Research
02

Partnerships

Bill & Melinda Gates FoundationNational Institutes of Health (NIH)PATHUniversity of Washington

Beyond the preview

Go deeper on SBRI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBRI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call